Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
2
pubmed:dateCreated
2004-8-5
pubmed:abstractText
A multicenter, randomized, open-label, crossover study with two 4-week evaluation periods compared patient preference and ease of teaching correct inhaler technique for Pulmicort Turbuhaler versus pressurized metered-dose inhalers (pMDIs). Patients 18 to 65 years of age with stable, mild to moderate asthma, who required or were eligible for inhaled corticosteroid therapy, were randomized to treatment sequences consisting of 4-week evaluation periods with Pulmicort Turbuhaler (budesonide inhalation powder) two puffs (400 microg) bid and one of three inhaled corticosteroids via pMDI: Aerobid-M (flunisolide) four puffs (1 mg) bid, Flovent (fluticasone propionate) two puffs (440 microg) bid, or Vanceril Double Strength (beclomethasone dipropionate) five puffs (420 microg) bid. Patients indicated device preference at study end and completed the Patient Device Experience Assessment (PDEA) questionnaire after each evaluation period. Ease of teaching, time required to master use of the device, percentage of patients demonstrating mastery on the first attempt, and the number of attempts required to demonstrate mastery were assessed. Despite previous use of pMDIs by most patients, Pulmicort Turbuhaler was significantly preferred (p < 0.001) and required significantly less time to master than pMDIs (p < 0.001). Median times to device mastery were 3.67 min for Pulmicort Turbuhaler versus 5.33 min for pMDIs. Patients rated Pulmicort Turbuhaler significantly better than pMDIs on PDEA ease of use (p = 0.0005) and overall satisfaction (p < 0.0001) single-item scales and all four multi-item scales (pharyngeal symptoms, oral sensation, operational use, and inhaler attributes; p < 0.05). Overall, patients preferred Pulmicort Turbuhaler over pMDIs and required less time to be taught how to correctly use Turbuhaler trade mark.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
T
pubmed:chemical
pubmed:status
MEDLINE
pubmed:issn
0894-2684
pubmed:author
pubmed:issnType
Print
pubmed:volume
17
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
129-39
pubmed:dateRevised
2007-11-15
pubmed:meshHeading
pubmed-meshheading:15294063-Administration, Inhalation, pubmed-meshheading:15294063-Adolescent, pubmed-meshheading:15294063-Adult, pubmed-meshheading:15294063-Aged, pubmed-meshheading:15294063-Anti-Asthmatic Agents, pubmed-meshheading:15294063-Asthma, pubmed-meshheading:15294063-Beclomethasone, pubmed-meshheading:15294063-Cross-Over Studies, pubmed-meshheading:15294063-Female, pubmed-meshheading:15294063-Follow-Up Studies, pubmed-meshheading:15294063-Humans, pubmed-meshheading:15294063-Inhalation Spacers, pubmed-meshheading:15294063-Male, pubmed-meshheading:15294063-Metered Dose Inhalers, pubmed-meshheading:15294063-Middle Aged, pubmed-meshheading:15294063-Nebulizers and Vaporizers, pubmed-meshheading:15294063-Patient Compliance, pubmed-meshheading:15294063-Patient Education as Topic, pubmed-meshheading:15294063-Patient Satisfaction, pubmed-meshheading:15294063-Probability, pubmed-meshheading:15294063-Statistics, Nonparametric, pubmed-meshheading:15294063-Treatment Outcome
pubmed:year
2004
pubmed:articleTitle
Comparison of patient preference and ease of teaching inhaler technique for Pulmicort Turbuhaler versus pressurized metered-dose inhalers.
pubmed:affiliation
Allergy & Asthma Medical Group and Research Center, San Diego, California 92123, USA. mwelch@pol.net
pubmed:publicationType
Journal Article, Clinical Trial, Comparative Study, Randomized Controlled Trial, Research Support, Non-U.S. Gov't, Multicenter Study